Apollo Endosurgery's long-term debt is $37M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Apollo Endosurgery (APEN) currently reports a long-term debt of $37M as of December 2022. That compares with $53M in the prior-year period — down 30.5% year over year. Use the charts on this page to explore Apollo Endosurgery's long-term debt history and peer comparisons.
Apollo Endosurgery's long-term debt decreased from $53M to $37M — a 30.5% year-over-year decrease (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Apollo Endosurgery reported $37M in long-term debt as of December 2022. That compares with $53M in the prior-year period — down 30.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current long-term debt of $37M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Apollo Endosurgery, and consider following APEN for alerts when major investors trade the stock.
Apollo Endosurgery is classified in the Healthcare sector. On long-term debt, it currently shows $37M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing APEN with unrelated industries.